Clinical trial
Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity
NCT04800159 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity
- Lead sponsor
- University of California, San Diego
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- February 19, 2021
- Completion date
- April 30, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cannabis use, hiv